1. Editorial: screening for oesophageal varices after directly acting anti‐viral therapy—do not let your guard down
   Sahaj Rathi et al, 2019, Alimentary Pharmacology & Therapeutics CrossRef
2. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis
   William R. Treem et al, 2021, Drug Safety CrossRef
3. Suppression of complement component 2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients
   Gang Ning et al, 2020, Journal of Viral Hepatitis CrossRef
4. Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review
   Mohamed A Abd El Aziz et al, 2020, Antiviral Chemistry and Chemotherapy CrossRef
5. Mortality trends in chronic liver disease and cirrhosis from 1981 to 2015 in Taiwan
   Shih-Yung Su et al, 2021, Population Health Metrics CrossRef
6. Population-based study of Entecavir and long-term mortality in chronic hepatitis B–related decompensated liver cirrhosis
   Tsung-Hsing Hung et al, 2019, Clinics and Research in Hepatology and Gastroenterology CrossRef
7. The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis
   Dan Peng et al, 2020, BMC Gastroenterology CrossRef
8. Current Management of Chronic HBV Infection
   Nese Inan et al, 2018, Viral Hepatitis: Chronic Hepatitis B CrossRef